Ciprofloxacin is amphoteric and possesses both acidic and basic properties
the verdict
CONTESTED
contested - the weight sits with the supporting side
refutedsupported
the weight of evidence
4 sources for · 0 against
Retrieved sources mention ciprofloxacin as a zwitterionic molecule and identify carboxylic acid and piperazinyl substituents, but do not provide explicit confirmation of amphoteric properties.
Pharmaceutical residues, now recognized as a new category of environmental pollutants, have potentially risks to both ecosystems and human health effects. Recently, biosorption has emerged as one of the most promising strategies for managing these pharmaceutical wastes in water. Nevertheless, the environmental impact of the adsorbents presents a challenge to the advancement of this process. Therefore, the present study proposed two biosorbent: Chlorella vulgaris and Synechocystis sp. microalgae to manage Ciprofloxacin (CIP) in water. The experimental findings revealed that the optimal conditions for adsorption conditions are CIP initial concentration 4.0 mg/L and pH 5 and 3 for Synechocystissp. and C. vulgaris, respectively. The adsorption process followed the Pseudo-second-order kinetic model. The main mechanism of biosorption is the complexation of CIP with carboxyl, hydroxyl, carbonyl, and amido groups which was confirmed by Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and energy-dispersive X-ray spectrometry (EDX) analyses. These analyses confirmed the presence of CIP on the surface of tested microalgal cells. These results indicated that the adsorption mechanism of CIP by Synechocystis sp. PCC6803 and C. vulgaris offers theoretical insights into the biosorption mechanisms of pharmaceutical residues.
Ciprofloxacin, a widely used second-generation fluoroquinolone for treating bacterial infections, has recently shown notable anticancer properties. This review explores progress in developing ciprofloxacin derivatives with anticancer properties, emphasizing key structural changes that improve their therapeutic effectiveness by modifying the basic group at position 7, the carboxylic acid group at position 3, or both. It further investigates the mechanisms by which these derivatives fight cancer, such as inducing apoptosis, arresting the cell cycle, inhibiting topoisomerase I and II, preventing tubulin polymerization, suppressing interleukin 6, blocking thymidine phosphorylase, inhibiting multidrug resistance proteins, and hindering angiogenesis. Additionally, it outlines their future directions, such as enhancing their efficacy, selectivity, and investigating potential synergy with other chemotherapeutic agents, offering a promising avenue for developing new therapies for cancer.
Ciprofloxacin is a quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively. It has a role as an antimicrobial agent, an antiinfective agent, a xenobiotic, an antibacterial drug, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a topoisomerase IV inhibitor, a DNA synthesis inhibitor and an environmental contaminant. It is a quinolone, a quinolinemonocarboxylic acid, an aminoquinoline, a N-arylpiperazine, a member of cyclopropanes, a quinolone antibiotic and a fluoroquinolone antibio
Fibroin nanoparticles (FNP) have been employed in numerous biomedical applications. However, limited research has focused on the oral delivery of FNP and in-depth molecular interactions between the encapsulated drug and FNP. Therefore, this work developed the FNP, functionalized with poly(vinyl alcohol) (PVA), to orally deliver the zwitterionic ciprofloxacin, focused on the molecular interactions. The particles were formulated using both desolvation (the drug precipitated during the particles formulation) and adsorption (the drug adsorbed on the particles surfaces) methods. The optimal formula
Everything we examined (4)
This check searched the claim as stated. It did not run a separate search for evidence against it.